# Ovizio Imaging Systems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ovizio-imaging-systems

- Industry: Medical Devices & Equipment
- Headquarters: Brussels, Belgium
- Website: www.ovizio.com
- Latest round: Seed (Dec 1, 2009)
- Investors on record: 2

## About

Ovizio Imaging Systems specializes in advanced imaging technologies, particularly for live cell analysis, providing innovative solutions that enhance laboratory workflows and facilitate precise cellular assessments in research and therapeutic applications.Founded in 2009, Ovizio Imaging Systems is based in Brussels, Belgium, and focuses on developing advanced imaging solutions for live cell analysis. The company was co-founded by Philip Mathuis and Serge Jooris. In November 2015, Ovizio raised EUR 8 million in funding from New Science Ventures and several other investors, which equals their total amount raised. Their operations have not indicated any significant pivots or changes in strategy, nor do they have any known subsidiaries.Ovizio Imaging Systems delivers high-throughput cell analysis solutions through flagship products like the Ovizio iLine F PRO Live Cell Analyzer, which integrates brightfield and fluorescence microscopy. Their systems facilitate accurate and efficient cell counting, processing up to 100 samples per hour and counting up to 100 million cells per milliliter, catering to sectors such as biotechnology and pharmaceuticals that require robust cell analysis capabilities.In the most recent year of 2017, Ovizio Imaging Systems reported a revenue of EUR 231,930.1. Their financial performance included an EBITDA of EUR -2,317,534.6 for the year 2022, indicating ongoing investment in operational growth and product development.Ovizio Imaging Systems intends to leverage the EUR 8 million raised in November 2015 to expand its product offerings and enhance market reach. The company is focused on developing new imaging solutions that could be launched in the near future and is exploring growth opportunities in both North America and Asia-Pacific. Specific timelines for product launches and market entry have not been disclosed but are part of their strategic vision for future development.

## Funding rounds

- Seed, Dec 1, 2009 — Seido Capital, Regional Investment Corporation Brussels

## Investors

- Seido Capital (https://capitalatlas.ai/funds/seido-capital) — Seed
- Regional Investment Corporation Brussels — Seed